If you hold shares in a private company that may go public, preparation comes down to three questions: what exactly do you own, when can you actually sell, and what will you owe in taxes when you do. Most pre-IPO investors get surprised on at least one of the three. The surprises are avoidable.
This guide covers what changes at an IPO, what stays the same longer than you'd expect, and the planning work that's better done months before a listing than the week after.
An IPO converts private shares into stock that trades on a public exchange. That's the part most people understand. The part that catches investors off guard is timing: your shares becoming tradable in principle and you being able to sell are two different events, often separated by months.
Between a company's first confidential filing and your first eligible sale date, a year or more can pass. The filing itself is not an offering, the offering is not your liquidity, and the listing date starts a clock rather than ending one. Investors who treat the IPO announcement as a payday tend to make planning mistakes in that gap.
Two investors holding stakes in the same company can have materially different outcomes from the same IPO. The variables are structural. What share class do you hold? Did you invest directly or through a special purpose vehicle? What lockup terms apply to your shares, and do they differ from the terms binding insiders? Each of these is set long before the listing, and none of them is negotiable afterward.
Start with how you hold the position, because it determines how much control you have over what happens next.
Direct shares. If you bought shares in a secondary transaction and hold them in your own name, you're on the company's cap table (or with its transfer agent). After the IPO and any applicable lockup, you generally decide when and how to sell, through your own brokerage account.
SPV participation. If you invested through a special purpose vehicle, the SPV holds the shares and you hold an interest in the SPV. The vehicle's manager decides when to sell or distribute, within the terms of the operating agreement. Some SPVs distribute shares in kind after lockup; others sell and distribute cash; some give members a choice. If you don't know which yours does, read the agreement now. This is the single most common gap in pre-IPO investors' understanding of their own positions.
Beyond the holding structure, check the rights and restrictions attached to your investment. Private shares often carry transfer restrictions, rights of first refusal, and information rights that change or terminate at an IPO. Preferred shares generally convert to common stock at listing, which can affect liquidation preferences you may have been counting on.
IPO timing is uncertain by design. Companies can file confidentially, sit on a filing for quarters, update it, and still pull the offering before pricing. Market conditions, sector sentiment, and the company's own results all factor into the decision, and none of them is visible to outside shareholders in real time.
Delays are common, and so are cancellations. A reported filing means a company has taken a step toward a potential listing, nothing more. Building a financial plan that depends on a specific IPO happening in a specific quarter is building on sand. The disclosure language used across the industry exists for a reason: an IPO or other liquidity event is not guaranteed.
At the IPO, outstanding private shares generally convert into shares of the publicly listed stock. Preferred stock usually converts to common, in most cases at a one-to-one ratio, though the exact mechanics depend on the company's charter. If you hold through an SPV, the vehicle's shares convert, and your interest in the vehicle is unchanged until the manager acts.
Conversion is automatic. What it doesn't do is move the shares into your brokerage account or make them sellable. That comes later.
Most pre-IPO investors cannot sell at the listing. Lockup agreements, signed as a condition of the offering, bar existing shareholders from selling for a set period after the IPO. Lockups most commonly run 90 to 180 days, with 180 the traditional standard.
The structure has gotten more varied in recent years. Some offerings include early-release provisions that free a portion of shares if the stock trades above a price threshold. Some use staggered releases. Direct listings may have no lockup at all. Your specific terms are in the documents you signed (or that your SPV manager signed), and they're worth confirming rather than assuming.
One pattern worth knowing about: lockup expiration dates are public, and trading volume around them can be elevated as restricted holders become eligible to sell at the same time. How that affects any given stock's price varies case by case.
This is a personal financial decision, not one this article can make for you, and it depends on factors only you and your advisors can weigh. The useful framing is a set of questions rather than an answer. How concentrated is this position relative to your total portfolio? What's your cost basis, and what would a sale mean after tax? Do you have near-term cash needs, or is this long-horizon capital? What's your conviction in the company as a public business, which is a different question from your conviction in it as a private one?
Some investors sell a portion at the first opportunity and hold the rest. Others hold through the volatility. Others exit entirely and redeploy. There's no formula here, and anyone selling you one is selling you something.
IPO pricing reflects what underwriters and institutional buyers agreed on for one day. It may not reflect where the stock trades a week, a quarter, or a year later, in either direction. Newly public stocks often trade with wider swings than seasoned listings, since the public float is small, the earnings history as a public company is nonexistent, and the shareholder base is still sorting itself out.
For a locked-up investor, this matters psychologically as much as financially. You may spend six months watching a paper gain double, halve, and double again before you're allowed to act. Some investors find it useful to decide in advance what they intend to do once shares become eligible for sale, rather than deciding in the moment.
Nothing in this section is tax advice. The rules are general, the exceptions are many, and your situation is specific. Talk to a qualified tax professional before the liquidity event, not after.
For directly held shares, the holding period for capital gains purposes generally runs from when you acquired the shares, not from the IPO date. Shares held for more than one year before sale are generally eligible for long-term capital gains rates; a year or less means short-term rates, which match ordinary income.
Investors who hear about Qualified Small Business Stock (QSBS) treatment should know one thing up front: QSBS benefits under Section 1202 generally require acquiring shares at original issuance from the company. Shares bought in secondary transactions usually do not qualify. If someone has suggested your secondary position carries QSBS treatment, that claim deserves professional scrutiny before you rely on it.
SPV investors have an additional layer: the vehicle's tax reporting (typically a K-1) and the timing of the manager's sale decisions both affect your outcome.
A large stock sale can create estimated-tax obligations long before the next filing deadline, and no one withholds taxes from a brokerage sale on your behalf. State residency matters too, since state treatment of capital gains varies widely.
The practical move is to engage your tax advisor and financial planner before the lockup expires, with your share count, cost basis, and acquisition dates in hand. The investors who do this in month two of the lockup have options; the ones who start in the week after expiration mostly have regrets.
The most common error, and the most expensive in planning terms. Investors commit to home purchases, fund obligations, or other deals on the assumption that IPO proceeds arrive at listing. They don't. Between lockups, SPV distribution timelines, and the possibility the IPO slips entirely, the money is real when it's in your account and not before.
The second most common error. A sale that looks like a win at the headline number can shrink considerably after federal and state taxes, especially for short-term holdings. Unexpected liabilities have a way of surfacing precisely when investors have already mentally spent the proceeds. Run the after-tax math before deciding anything.
Augment operates a private marketplace where accredited investors can see secondary-market activity in late-stage private companies, including names that may be moving toward public listings based on reported filings.
For shareholders who want liquidity before an IPO rather than after a lockup, secondary transactions are one path. Selling pre-IPO shares is subject to issuer transfer restrictions and approvals, buyer availability, and market conditions, and is not available for every company or every position. Where transactions are possible, Augment's platform provides a structured process to facilitate the transfer, subject to issuer approval.
Investors looking to build pre-IPO exposure rather than exit it can explore Augment Collective, which provides structured access to late-stage private companies for accredited investors.
Preparation is mostly about closing the gap between what you assume and what your documents actually say. The IPO converts your shares; it doesn't deliver your liquidity. The lockup sets your earliest sale date; your tax situation shapes what a sale is worth; and the listing itself may slip, in which case all of this planning waits with it.
The work is unglamorous: read the operating agreement, confirm the lockup terms, run the after-tax numbers with a professional, and decide your plan before the expiration date decides it for you.
For accredited investors who'd rather not wait on a listing that may or may not arrive on schedule, the secondary market exists precisely because IPO timelines stretched. Pre-IPO liquidity, where available, is the alternative the private market built for itself.

FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement.Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. “Investment accounts” are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC’s Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.